Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

As healthcare evolves at a remarkable pace, innovation in pharmaceuticals has become more than a matter of science but rather a matter of public impact. Few scientists embody this convergence better ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...

Doug Long, BA, MBA, vice president of Industry Relations at IQVIA, shares what's happening in the growing GLP-1 and biosimilars space. Long was a presenter at the annual AMCP 2025 meeting in Houston, ...

Shares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S.

“Gen Z loves a rebrand, so when kombucha legacy Health Ade created a Gen Z targeted brand, Sun Sip, Gen Z was all in,” Kaufman says. “With a focus on gut health, vibrant packaging and smart influencer ...

The United States is amid a dangerous drug shortage. It’s a crisis that endangers patients, undermines our health care system ...

Vermont Business Magazine Today, the Senate Judiciary Committee has advanced a slate of bipartisan bills to lower the cost of prescription drugs, including several sponsored by Senator Peter Welch ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

The Trump administration has waived reciprocal tariffs on India's pharmaceutical sector, highlighting its critical role in ...